Alignment Healthcare, Inc. Stock Price, News & Analysis

Alignment Healthcare (Nasdaq: ALHC) is set to announce its Q4 and full-year 2021 financial results on March 3, 2022, after the market closes. A conference call will follow at 5 p.m. E.T. for discussion of these results. The call can be accessed through specific dialing codes for U.S. and international participants and will also be available via a live audio webcast. Alignment Healthcare aims to deliver tailored healthcare solutions, focusing on seniors and the chronically ill, through its Medicare Advantage plans.

Alignment Healthcare, a tech-enabled Medicare Advantage company, reported that its Q4 2021 inpatient utilization was about 5% lower than expected, highlighting the effectiveness of its AVA health platform. The company's health plan membership reached 92,700 as of January 1, 2022, marking a 16% increase from January 2021. Alignment remains focused on innovation, coordinated care, and expanding partnerships with major providers while serving 38 counties across four states and offering over 40 health plans.

Alignment Healthcare, a tech-enabled Medicare Advantage company, announced participation in the 40th Annual J.P. Morgan Healthcare Conference. CEO John Kao and CFO Thomas Freeman will present on January 12, 2022, at 4:30 p.m. E.T. An audio replay will be available on their website.

Alignment Healthcare focuses on consumer-centric healthcare for seniors and chronically ill patients through customized Medicare Advantage plans. The company emphasizes clinical coordination, risk management, and technology facilitation to improve care delivery and reduce costs.

Alignment Healthcare (NASDAQ: ALHC) has appointed Jody Bilney and Yon Yoon Jorden to its Board of Directors, effective January 1, 2022. This decision expands the board from nine to eleven members, enhancing female representation to over one-third. Bilney, a former chief consumer officer at Humana, brings extensive experience in business strategy and transformation, while Jorden has held several senior management roles in healthcare services. The company aims to leverage their expertise to scale operations nationwide and improve care for seniors.

GRAIL, LLC has partnered with Alignment Health Plan to provide Medicare Advantage members in California and North Carolina access to Galleri®, a multi-cancer early detection blood test. Starting January 1, 2022, new and existing members can obtain the test, which detects over 50 cancers, many of which lack standard screenings. The initiative aims to enhance cancer detection among seniors, thereby potentially reducing late-stage diagnoses.

Alignment Healthcare announced the completion of its public offering of 9,200,000 shares of common stock at $21.00 per share. The offering included the full exercise of underwriters' option for an additional 1,200,000 shares. Proceeds will not benefit the company, as shares are sold by existing stockholders. The registration statement was effective as of November 18, 2021. Major financial institutions participated as book-running managers in the offering. This move reflects Alignment Healthcare's ongoing strategy to enhance its Medicare Advantage services without direct financial inflow from the sale.

Alignment Healthcare announces enhancements to its Medicare Advantage plans for 2022, focusing on improved prescription drug coverage. Key features include $0 copays for many medications, virtual care orders, and at-home delivery services. Over 70% of prescriptions in Arizona, Nevada, and North Carolina will be available at no cost. The plan has received the Pharmacy Quality Alliance Excellence in Quality Award for four consecutive years, reflecting its commitment to high-quality Medicare services. Enrollment is open until Dec. 7, 2021, for benefits starting Jan. 1, 2022.

Alignment Healthcare, a tech-enabled Medicare Advantage company (Nasdaq: ALHC), announced that CEO John Kao and CFO Thomas Freeman will speak at the Piper Sandler 33rd Annual Healthcare Conference on Dec. 1, 2021, at 11:00 a.m. E.T. The event will include a fireside chat, and the webcast link can be found on their investor relations page. Alignment Healthcare focuses on delivering customized healthcare services to seniors and chronically ill individuals through their Medicare Advantage plans, enhancing care coordination and managing health risks effectively.

Alignment Healthcare announced the pricing of an underwritten public offering of 8,000,000 shares at $21.00 each, with an option for underwriters to purchase an additional 1,200,000 shares. The offering does not benefit Alignment Healthcare, as the proceeds will go to selling stockholders, who will cover related costs. The offering is set to close on November 23, 2021. The registration statement was declared effective on November 18, 2021, by the SEC. Major banks, including Goldman Sachs and Morgan Stanley, are managing the offering, which is subject to customary closing conditions.